THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Magdalena Bieniasz

Concepts (138)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
5
2022
566
1.370
Why?
Antineoplastic Agents
2
2022
657
0.860
Why?
Genetic Vectors
1
2022
107
0.800
Why?
Cystadenocarcinoma, Serous
1
2021
31
0.750
Why?
Disease Susceptibility
1
2021
72
0.750
Why?
Biological Products
1
2022
60
0.740
Why?
Transcription Factors
2
2022
514
0.740
Why?
Cell Transformation, Neoplastic
1
2021
114
0.720
Why?
Nuclear Proteins
1
2022
245
0.710
Why?
Cell Cycle Proteins
1
2021
185
0.670
Why?
Receptor Protein-Tyrosine Kinases
1
2015
50
0.490
Why?
Lung Neoplasms
2
2009
340
0.470
Why?
Protein Kinase Inhibitors
1
2015
143
0.460
Why?
Protein Isoforms
2
2022
118
0.390
Why?
Gene Expression Regulation, Neoplastic
4
2021
444
0.380
Why?
Xenograft Model Antitumor Assays
4
2022
250
0.360
Why?
Breast Neoplasms
1
2015
446
0.340
Why?
Metal Nanoparticles
2
2022
128
0.330
Why?
Animals
8
2022
10065
0.330
Why?
Bone Morphogenetic Protein 2
1
2009
29
0.320
Why?
Tissue Inhibitor of Metalloproteinases
1
2008
13
0.300
Why?
Vascular Endothelial Growth Factor A
1
2009
177
0.300
Why?
Matrix Metalloproteinases
1
2008
31
0.300
Why?
Bone Morphogenetic Proteins
1
2008
32
0.290
Why?
Carcinoma, Non-Small-Cell Lung
1
2009
102
0.290
Why?
Female
8
2022
14625
0.230
Why?
Disease Models, Animal
2
2022
1405
0.220
Why?
Cloning, Molecular
2
2022
205
0.220
Why?
Humans
12
2022
27127
0.200
Why?
Mammals
1
2022
46
0.200
Why?
Genomic Instability
1
2021
33
0.190
Why?
Mice
4
2022
4466
0.190
Why?
Structure-Activity Relationship
1
2021
204
0.190
Why?
Receptors, Cell Surface
1
2021
109
0.190
Why?
Mebendazole
1
2020
10
0.180
Why?
Nerve Tissue Proteins
1
2021
151
0.180
Why?
Molecular Targeted Therapy
1
2021
125
0.180
Why?
Drug Resistance, Neoplasm
1
2021
149
0.170
Why?
Reproducibility of Results
1
2022
751
0.160
Why?
Cell Line, Tumor
3
2020
1268
0.160
Why?
Biomarkers, Tumor
1
2021
377
0.160
Why?
Nanoparticles
1
2020
275
0.130
Why?
Prognosis
2
2009
762
0.130
Why?
Proto-Oncogene Proteins c-met
1
2015
12
0.130
Why?
Receptors, Progesterone
1
2015
17
0.130
Why?
Receptors, Estrogen
1
2015
42
0.120
Why?
Tumor Burden
1
2015
108
0.120
Why?
Phosphatidylinositol 3-Kinases
1
2015
134
0.120
Why?
Oncolytic Virotherapy
2
2011
12
0.120
Why?
Vaccinia virus
1
2011
6
0.100
Why?
Apoptosis
1
2015
738
0.100
Why?
Mutation
1
2015
821
0.090
Why?
Neoplasms, Experimental
1
2011
57
0.090
Why?
Alleles
2
2009
347
0.090
Why?
Genotype
2
2009
444
0.090
Why?
Recombinant Fusion Proteins
2
2009
229
0.090
Why?
Gold
2
2022
129
0.090
Why?
Activated-Leukocyte Cell Adhesion Molecule
1
2009
2
0.080
Why?
Cancer Vaccines
1
2009
32
0.080
Why?
Gene Expression
2
2009
407
0.080
Why?
Bone Morphogenetic Protein 4
1
2009
14
0.080
Why?
Neuroblastoma
1
2009
56
0.080
Why?
ADP-ribosyl Cyclase 1
1
2009
10
0.080
Why?
Signal Transduction
1
2015
1374
0.080
Why?
CD8-Positive T-Lymphocytes
1
2009
91
0.080
Why?
Receptors, Urokinase Plasminogen Activator
1
2008
11
0.080
Why?
DNA Mutational Analysis
1
2009
90
0.080
Why?
Urokinase-Type Plasminogen Activator
1
2008
11
0.080
Why?
Plasminogen Activator Inhibitor 1
1
2008
20
0.080
Why?
Hirudins
1
2008
17
0.080
Why?
Tissue Plasminogen Activator
1
2008
36
0.080
Why?
Metalloendopeptidases
1
2008
39
0.080
Why?
Antithrombins
1
2008
28
0.080
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2009
40
0.080
Why?
Polymorphism, Genetic
1
2009
163
0.080
Why?
Dendritic Cells
1
2009
143
0.070
Why?
Neoplasm Staging
1
2009
463
0.070
Why?
Polymorphism, Single Nucleotide
1
2009
544
0.070
Why?
Lung
1
2009
360
0.070
Why?
Endothelial Cells
1
2008
340
0.060
Why?
Genetic Predisposition to Disease
1
2009
665
0.060
Why?
Oxidative Stress
1
2008
630
0.060
Why?
Aged, 80 and over
1
2009
1935
0.060
Why?
PTEN Phosphohydrolase
1
2022
29
0.050
Why?
Tissue Distribution
1
2022
132
0.050
Why?
TOR Serine-Threonine Kinases
1
2022
76
0.050
Why?
Fenbendazole
1
2020
8
0.050
Why?
Quinuclidines
1
2020
10
0.050
Why?
Drug Repositioning
1
2020
11
0.050
Why?
Insulin
1
2022
313
0.040
Why?
Drug Synergism
1
2020
100
0.040
Why?
Drug Screening Assays, Antitumor
1
2020
102
0.040
Why?
Random Allocation
1
2020
148
0.040
Why?
Tumor Suppressor Protein p53
1
2020
99
0.040
Why?
Liposomes
1
2020
142
0.040
Why?
RNA, Small Interfering
1
2020
195
0.040
Why?
Aged
1
2009
5217
0.040
Why?
Polymerase Chain Reaction
2
2009
262
0.040
Why?
Middle Aged
1
2009
6901
0.040
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
375
0.030
Why?
Male
1
2009
13008
0.030
Why?
Virus Replication
1
2011
62
0.020
Why?
Neoplasm Metastasis
1
2011
151
0.020
Why?
Mice, Nude
1
2011
312
0.020
Why?
Flow Cytometry
1
2011
285
0.020
Why?
Immunohistochemistry
1
2011
455
0.020
Why?
Gangliosides
1
2009
3
0.020
Why?
Mice, Inbred A
1
2009
14
0.020
Why?
Adoptive Transfer
1
2009
25
0.020
Why?
Whole-Body Irradiation
1
2009
38
0.020
Why?
Receptors, IgG
1
2009
47
0.020
Why?
Poland
1
2009
5
0.020
Why?
Kaplan-Meier Estimate
1
2009
189
0.020
Why?
Nitroprusside
1
2008
8
0.020
Why?
Nitric Oxide Donors
1
2008
11
0.020
Why?
Statistics, Nonparametric
1
2009
80
0.020
Why?
Plasminogen
1
2008
8
0.020
Why?
Pichia
1
2008
5
0.020
Why?
Hypoxia-Inducible Factor 1
1
2008
11
0.020
Why?
Linkage Disequilibrium
1
2009
107
0.020
Why?
Transcription Factor AP-1
1
2008
26
0.020
Why?
Fibrinolysis
1
2008
21
0.020
Why?
Chi-Square Distribution
1
2009
144
0.020
Why?
Oxidants
1
2008
30
0.020
Why?
Disulfides
1
2008
33
0.020
Why?
Epitopes
1
2009
176
0.020
Why?
DNA Primers
1
2008
143
0.020
Why?
Hydrogen Peroxide
1
2008
138
0.020
Why?
Electrophoresis, Polyacrylamide Gel
1
2008
165
0.020
Why?
NF-kappa B
1
2008
187
0.020
Why?
Logistic Models
1
2009
398
0.020
Why?
Nitric Oxide
1
2008
152
0.020
Why?
Base Sequence
1
2008
573
0.020
Why?
Recombinant Proteins
1
2008
408
0.020
Why?
Promoter Regions, Genetic
1
2008
333
0.020
Why?
Magnetic Resonance Imaging
1
2011
810
0.020
Why?
Case-Control Studies
1
2009
706
0.020
Why?
Cells, Cultured
1
2008
975
0.020
Why?
Bieniasz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (138)
Explore
_
Co-Authors (13)
Explore
_
Similar People (60)
Explore
_
Physical Neighbors
_

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES